International Journal of Academic Health and Medical Research (IJAHMR)   Year: 2021 | Volume: 5 | Issue: 4 | Page No.: 72-74 Carcinosarcoma Of The Ovary: A Case Report And Review Of The Literature Kamal Aboulfath, yassine El Baraka,jalila Rahmouni, K.Mohammed Saoud,N.Mamouni,S.Errarhay,C.Bouchikhi ;A .Banani Abstract: Ovarian carcinosarcoma (OCS) also called mixed mesodermal tumor or mixed mullerian tumor with a double component: epithelial and sarcomatous rare gynecological tumor that represents less than 2% of ovarian cancers. In the genital tract, it is most often found in the uterus. The ovary, cervix or vagina are more rarely affected. Carcinosarcoma affects women between the ages of 60 and 70. The main prognostic factor found is the initial stage, most often advanced: At diagnosis, more than 90% of ovarian carcinosarcomas have a locoregional extension. The surgical management is a determining factor for the survival of patients. Carcinosarcoma is an aggressive tumor, the median survival is 7 to 27 months for ovarian carcinosarcomas. Relapse occurs mainly in the first year. FIGO stage is the most important prognostic factor. Complete surgery, advanced age, grade of the sarcomatous component, and adjuvant chemotherapy are found in the few published retrospective studies. The response rate to chemotherapy is about 20%. Our objective is to report a case of ovarian carcinosarcoma while performing a literature review.